Predictors of severe right ventricular failure after Implantable left ventricular assist device insertion: Analysis of 245 patients

被引:359
作者
Ochiai, Y
McCarthy, PM
Smedira, NG
Banbury, MK
Navia, JL
Feng, JY
Hsu, AP
Yeager, ML
Buda, T
Hoercher, KJ
Howard, MW
Takagaki, M
Doi, K
Fukamachi, K
机构
[1] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Kaufman Ctr Heart Failure, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Transplant Ctr, Cleveland, OH 44195 USA
关键词
cardiomyopathy; heart-assist device; heart failure; surgery;
D O I
10.1161/01.cir.0000032906.33237.1c
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Insertion of an implantable left ventricular assist device (LVAD) complicated by early right ventricular (RV) failure has a poor prognosis and is largely unpredictable. Prediction of RV failure after LVAD placement would lead to more precise patient selection and optimal device selection. Methods and Results-We reviewed data from 245 patients (mean age, 54+/-11 years; 85% male) with 189 HeartMate (77%) and 56 Novacor (23%) LVADs. Ischemic cardiomyopathy predominated (65%), and 29% had dilated cardiomyopathy. Overall, RV assist device (RVAD) support was required after LVAD insertion for 23 patients (9%). We compared clinical and hemodynamic parameters before LVAD insertion between RVAD (n=23) and No-RVAD patients (n=222) to determine preoperative risk factors for severe RV failure. By univariate analysis, female gender, small body surface area, nonischemic etiology, preoperative mechanical ventilation, circulatory support before LVAD insertion, low mean and diastolic pulmonary artery pressures (PAPs), low RV stroke work (RVSW), and low RVSW index (RVSWI) were significantly associated with RVAD use. Elevated PAP and pulmonary vascular resistance were not risk factors. Risk factors by multivariable logistic regression were preoperative circulatory support (odds ratio [OR], 5.3), female gender (OR, 4.5), and nonischemic etiology (OR, 3.3). Conclusions-The need for circulatory support, female gender, and nonischemic etiology were the most significant predictors for RVAD use after LVAD insertion. Regarding hemodynamics, low PAP and low RVSWI, reflecting low RV contractility, were important parameters. This information tray lead to better patient selection for isolated LVAD implantation.
引用
收藏
页码:I198 / I202
页数:5
相关论文
共 25 条
[1]   Discussion of bridging to transplant and alternatives to transplant [J].
Copeland, JG ;
Pavie, AJ ;
El-Banayosy, A ;
Oz, MC ;
Hetzer, R ;
Scholl, F ;
Vega, JD ;
Frazier, OH ;
Samuels, LE .
ANNALS OF THORACIC SURGERY, 2001, 71 (03) :S114-S115
[2]  
Deng MC, 2001, CIRCULATION, V103, P231
[3]   Initial experience with the AbioCor implantable replacement heart at the University of Louisville [J].
Dowling, RD ;
Etoch, SW ;
Stevens, K ;
Butterfield, A ;
Koenig, SE ;
Johnson, A ;
Chiang, B ;
Gray, LA .
ASAIO JOURNAL, 2000, 46 (05) :579-581
[4]   Device and patient management in a bridge-to-transplant setting [J].
El-Banayosy, A ;
Körfer, R ;
Arusoglu, L ;
Kizner, L ;
Morshuis, M ;
Milting, H ;
Tenderich, G ;
Fey, O ;
Minami, K .
ANNALS OF THORACIC SURGERY, 2001, 71 (03) :S98-S102
[5]   Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation [J].
Farrar, DJ ;
Hill, JD ;
Pennington, DG ;
McBride, LR ;
Holman, WL ;
Kormos, RL ;
Esmore, D ;
Gray, LA ;
Seifert, PE ;
Schoettle, GP ;
Moore, CH ;
Hendry, PJ ;
Bhayana, JN .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (01) :202-209
[6]   IMPROVED MORTALITY AND REHABILITATION OF TRANSPLANT CANDIDATES TREATED WITH A LONG-TERM IMPLANTABLE LEFT-VENTRICULAR ASSIST SYSTEM [J].
FRAZIER, OH ;
ROSE, EA ;
MCCARTHY, P ;
BURTON, NA ;
TECTOR, A ;
LEVIN, H ;
KAYNE, HL ;
POIRIER, VL ;
DASSE, KA .
ANNALS OF SURGERY, 1995, 222 (03) :327-338
[7]   Research and development of an implantable, axial-flow left ventricular assist device: The Jarvik 2000 heart [J].
Frazier, OH ;
Myers, TJ ;
Jarvik, RK ;
Westaby, S ;
Pigott, DW ;
Gregoric, ID ;
Khan, T ;
Tamez, DW ;
Conger, JL ;
Macris, MP .
ANNALS OF THORACIC SURGERY, 2001, 71 (03) :S125-S132
[8]   Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion [J].
Fukamachi, K ;
McCarthy, PM ;
Smedira, NG ;
Vargo, RL ;
Starling, RC ;
Young, JB .
ANNALS OF THORACIC SURGERY, 1999, 68 (06) :2181-2184
[9]   USE OF APROTININ IN LVAD RECIPIENTS REDUCES BLOOD-LOSS, BLOOD USE, AND PERIOPERATIVE MORTALITY [J].
GOLDSTEIN, DJ ;
SELDOMRIDGE, JA ;
CHEN, JM ;
CATANESE, KA ;
DEROSA, CM ;
WEINBERG, AD ;
SMITH, CR ;
ROSE, EA ;
LEVIN, HR ;
OZ, MC .
ANNALS OF THORACIC SURGERY, 1995, 59 (05) :1063-1068
[10]   Right ventricular performance and contractile reserve in patients with severe heart failure - Assessment by pressure-area relations and association with outcome [J].
Gorcsan, J ;
Murali, S ;
Counihan, PJ ;
Mandarino, WA ;
Kormos, RL .
CIRCULATION, 1996, 94 (12) :3190-3197